ASIC Ategrity Specialty Insurance Co Holdings Insider Trading

Officer Chris Schenk purchases 2,500 shares of ASIC in open-market buy amid stock pullback from recent highs.

Chris Schenk, an officer of Ategrity Specialty Insurance, executed an open-market purchase of shares as the stock was trading well below its recent highs, suggesting conviction that the current level represents value. The company itself is fundamentally sound—profitable with strong revenue growth and reasonable valuation—making this a potentially meaningful vote of confidence from someone with operational visibility. What's notable is the timing: Schenk bought into weakness rather than euphoria, and the purchase size is material enough to signal genuine personal commitment rather than routine vesting settlement. However, a single officer purchase, while positive, doesn't constitute a pattern yet; true insider buying conviction typically shows up as multiple executives accumulating simultaneously.

CEO Cohen buys 5,200 shares of ASIC at $19.41; inaugural purchase with stock down 23.2% from 52-week high.

Justin G Cohen, Chief Executive Officer, purchased 5,200 shares at $19.41 on 2025-10-27 for a total value of $100,937.72, representing his first open-market purchase in the filing record. The transaction occurs as ASIC trades at $18.96, approximately 23.2% below the 52-week high of $24.68, and down 2.9% and 3.8% over the prior 30 and 90 days respectively. The company's fundamentals remain intact with latest quarterly revenue of $101,800,000.00 and net income of $17,622,000.00 against a market cap of $911,344,139.04. This initial acquisition by the CEO warrants monitoring to assess whether it reflects selective capital deployment or establishes a new pattern of executive investment in the company.

Director Zimmer Stuart J. bought 11,130 shares over two days (Sept 29–30) at $19.41 blended average amid 27.6% decline from 52-week high

Stuart J. Zimmer, a director at Ategrity Specialty Insurance, made two separate open-market purchases totaling 11,130 shares for $216,088.73 on 2025-09-29 and 2025-09-30, with a blended average price of $19.41. The stock is currently trading at $17.88, down 27.6% from its 52-week high of $24.68 and -21.0% over the prior 30 days, reflecting recent weakness in the equity. His prior trades at this ticker (buys on 2025-09-26, 2025-09-25, and 2025-08-13) show a pattern of acquisition activity in the same period, though only the 2025-08-13 purchase has measurable outcomes (30-day return +7.8%). The cross-ticker track record shows 3 prior open-market buys with an average 30-day return of +7.8%, but this provides limited precision on timing expectations at ASIC specifically.

Director Zimmer Stuart J. purchased 9,920 shares at blended $19.45 on ASIC amid -22.2% decline from 52-week high

Director Stuart J. Zimmer executed 2 separate purchases totaling 9,920 shares for $192,901.77 at a blended average price of $19.45 on consecutive dates (2025-09-25 and 2025-09-26), increasing his holdings to 38,527,411 shares post-transaction. The timing coincides with material price weakness: the stock is trading $19.19 (current price), down 22.2% from its 52-week high of $24.68 and down 15.2% over the prior 30 days. While the company shows fundamentally solid metrics with revenue of $101,780,000.00 and net income of $17,622,000.00, the purchase at depressed levels represents a modest addition (0.0% net change vs. pre-transaction holdings) rather than a major commitment. The director's prior same-ticker buy on 2025-08-13 generated a positive 30d return of 7.8%, but outcomes at the 90-day mark remain incomplete, limiting inference about timing accuracy at this specific ticker.

Director Zimmer Stuart J. purchased 5,051 shares of ASIC at $19.49 on 2025-08-13 for $98,425.81.

Director Zimmer Stuart J. acquired 5,051 shares at $19.49, increasing his holdings from 38,512,440 to 38,517,491 shares. The transaction represents a minimal 0.0% increase to his existing position. The purchase price of $19.49 sits near the lower end of the 52-week range of $18.68–$24.68, roughly 9% below the current price of $21.47. Against the backdrop of quarterly revenue of $101,780,000 and net income of $17,622,000, the company maintains a market cap of $1,031,991,490.78. The modest share count addition to an already substantial holding warrants standard disclosure review but does not yet signal a material shift in insider positioning.

CFO Neelam Patel buys 20,000 shares of ASIC at $17.00 for $340,000.00 in first purchase since recent listing

CFO Neelam Patel purchased 20,000 shares at $17.00 on 2025-06-12, representing an initial position in ASIC following the company's recent listing 29 trading days prior. The $340,000.00 investment establishes the CFO's first shareholding, with the stock currently trading at $20.82 as of 2025-07-23. This represents the CFO's opening position in the company rather than an addition to existing holdings, providing a baseline for monitoring future trading patterns in the post-IPO period.

Director William S Mercer bought 7,300 shares of ASIC at $17.00 on 2025-06-12; 4 other insiders also bought within 14 days.

Director William S Mercer purchased 7,300 shares at $17.00 for $124,100.00, establishing an initial position in Ategrity Specialty Insurance Co Holdings four trading days after its listing. The transaction occurred at a $6.50-per-share discount to the current price of $23.50, representing a 38% appreciation since purchase. This buy activity is part of a cluster pattern in which 4 other insiders also acquired shares within the past 14 days, suggesting broad internal confidence at the post-IPO entry point. The convergence of insider buying at the listing-stage entry price warrants attention as a signal of early-stage insider participation in the company's capital structure.

Director Pressman Mitchell Brad bought 2,500 shares of ASIC at $17.00 on 2025-06-12; cluster pattern with 4 other insiders also buying within 14 days

Director Pressman Mitchell Brad purchased 2,500 shares at $17.00 totaling $42,500.00, expanding his holdings from 93,787 to 96,287 shares (net change +2.7%). The transaction is noteworthy because it is part of a broader cluster pattern: 4 other insiders also made purchases within the same 14-day window. This coordinated buying activity by multiple insiders shortly after ASIC's recent listing (4 trading days as of the current price reference) suggests aligned sentiment among the board and management regarding the company's near-term outlook. The current market price of $23.50 represents a significant move from the $17.00 transaction price, though establishing longer-term valuation context is constrained by the company's recent public debut.

Director Merton Robert C buys 47,058 shares of ASIC at $17.00 ($799,986.00); 4 other insiders also bought within 14 days.

Director Robert C. Merton purchased 47,058 shares at $17.00, establishing an initial position of 47.1K shares just four trading days after ASIC's recent listing. The transaction value of $799,986.00 represents a meaningful commitment by a board member at the IPO price point. Critically, this buy is part of a cluster pattern where 4 other insiders also made purchases within the past 14 days, suggesting coordinated or independently concurrent accumulation immediately following the company's public market entry. The stock has already moved to $23.50, indicating upward price momentum post-listing, though the recent timing and limited trading history preclude assessment of whether this reflects normal IPO price discovery or validates any insider conviction at the $17.00 entry.

Director Sennott John Langton Jr. buys 29,400 shares of ASIC at $17.00 ($499.8K); 4 other insiders bought within 14 days.

Director Sennott John Langton Jr. purchased 29,400 shares at $17.00 on 2025-06-12, establishing an initial position worth $499,800.00 just 4 trading days after the company's recent listing. The stock is currently trading at $23.50, representing price appreciation since his purchase. Notably, this transaction is part of a broader pattern in which 4 other insiders have also bought within the past 14 days, indicating coordinated director-level confidence in the company at its early public stage. The clustering of insider purchases across multiple participants at or near the listing price warrants investor attention as a signal of unified conviction in the company's value proposition at IPO.